Results
tumor, seroma, infiltrative ductal carcinoma
DUCTAL CARCINOMA IN SITU, TUMOR, DCIS, IDC, LOBULAR CARCINOMA IN SITU, LCIS, SENTINEL LYMPH NODE, SEROMA, LOBULAR CARCINOMA
Between September 2013 and December 2017, 87 patients were included. Forty-three patients were randomly assigned to the quilting group and 44 were assigned to the control group. There were no intergroup differences with regard to age, body mass index, neoadjuvant therapy, or tumor histology (Table Population characteristics. IDC: infiltrative ductal carcinoma, ILC: infiltrative lobular carcinoma, DCIS: ductal carcinoma in situ, LCIS: lobular carcinoma in situ, ALND: axillary lymph node dissection, SLND: sentinel lymph node dissection, CT: chemotherapy.The operating time was 17 min longer in the quilting group than in the control group (mean: 128.7 ± 40.7 Peroperative and immediate postoperative characteristics.Overall, 33 of the 87 patients (37.9%) had seroma 15 days after surgery (Table Postoperative consultations.More than 80% of patients in padding group were satisfied with the esthetic outcome; this value was 76% in the control group (Table Aesthetic results on postoperative day 90.